Pier Paolo Pandolfi currently lives in Reno, Nevada, but he is actually native to Italy. Born in Rome, he grew up in Italy and attended the University of Perugia, Italy, earning his M.D. and Ph.D. Eventually, his career led him to the United States, where he now has dual citizenship.
Professionally, Pier Paolo is an accomplished cancer researcher with over 500 articles published in medical journals. He was instrumental in developing a cure for acute promyelocytic leukemia, or APL, which was once considered a fatal disease.
Thanks to his high level of accomplishment, Pier Paolo Pandolfi has had many opportunities to travel. In addition to working in the United States and Italy, he has visited many other countries for conferences, research, and speaking engagements. This includes Spain, Germany, Singapore, Canada, and more. He loves getting to explore new places, as well as share his knowledge and experience with the medical community across the world.
Currently, Pier Paolo Pandolfi works as the Scientific Director and Principal Senior Scientist at the William N. Pennington Cancer Institute. Additionally, he is a Distinguished Honorary Professor of Cancer Genetics & Molecular Biology at Italy’s University of Turin. Over the years, Pier Paolo has spent a lot of time investing in education, teaching courses and supporting numerous graduate students and post-doctoral candidates. Pier Paololoves investing in medical students and helping form the next generation of researchers.
In addition to his own research efforts, Pier Paolo Pandolfi works with multiple medical journals to ensure other researchers are able to make their findings accessible. Currently, he is on the editorial board of three journals: Cancer Discovery, Molecular Cancer Therapeutics, and Molecular Oncology. Additionally, he has been an invited reviewer for numerous other journals.
Pier Paolo Pandolfi has filed two patents and currently has two active research grants. The goal of his laboratory is to understand the molecular genetics and mechanisms that lead to tumorigenesis. This involved extensive genetic research and is helping make strides in understanding the pathogenesis of various leukemias, lymphomas, and solid tumors. Pier Paolo and his team have made discoveries that have led to the development of novel therapeutic strategies that are actively improving outcomes for cancer patients.
In his free time, Pier Paolo Pandolfi has several hobbies that he enjoys. He loves to sail and hike when the weather is nice, exploring new places and enjoying the beauty of nature wherever he happens to be. He also loves literature and listening to classical music.
